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ABsTRACT
The aim of this study was to investigate the plasma and tissue levels of nesfatin-1 and irisin hormones, which were 
discovered in recent years and are associated with endocrine and metabolic functions, in kumiss-supplemented mice. 
Sixteen BALB/C male mice were divided into two groups as control and kumiss groups. During the experiment, the 
kumiss was added to the drinking water of mice at a ratio of 1:1 to obtain a daily 2×108 cfu/mL bacterial colony, and 
was given once a day orally for 20 weeks. The weights and food intake of the animals were monitored during the 
experiment. The nesfatin-1 and irisin levels in plasma and tissue samples were determined using ELISA kits. Kumiss 
supplementation reduced the live weight for 2-12 weeks (P<0.05). However, no significant difference was observed 
after the 12th week. The feed consumption of the kumiss group was lower at the beginning and the 10th week, and 
at the end, compared to the control group (P<0.05). The plasma levels of nesfatin-1 and irisin (P<0.001) decreased 
while the liver levels increased (P<0.05 and P<0.001, respectively). The results indicate that plasma and liver levels 
of nesfatin-1 and irisin are regulated by diet and are effective in weight loss and food intake. 
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kumiss has a higher alcohol and lactic acid content. 
The consumption of kumiss has been reported to 
have healthy effects on gastrointestinal, respiratory, 
immune, circulatory, cardiovascular, nervous and 
endocrine systems (DANOVA et al., 2005). 
Nesfatin-1 was first identified in 2006 as an 
82-amino-acid peptide derived from nucleobindin 2 
(NUCB2), a 396-amino-acid protein exceptionally 
conserved across mammalian species (OH-
I et al., 2006, FINELLI et al., 2014). It has been 
reported that nesfatin-1 is closely associated with 
introduction
Kumiss (also known as kumiss, kumis, kymis, 
kymmyz) is a traditional fermented drink made from 
mare's milk, which is commonly preferred in Central 
Asia. Mare's milk is important for nutrition, with 
a high amount of polyunsaturated fatty acids, low 
cholesterol content and different protein structure. 
The beneficial effects of the kumiss on health are 
due to the lactic acid bacteria and yeast contents, 
which are two different types of microorganisms, 
and their biological activities. Compared to other 
fermented milk products, such as yogurt and kefir, 
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food intake, energy expenditure, body weight 
reduction, diabetes, obesity, psychiatric disorders 
and neurogenic diseases (DAI et al., 2013). Irisin 
is a novel peptide associated with exercise secreted 
from skeletal muscle. Irisin, first discovered by 
BOSTROM et al. (2012), is produced from its 
precursor fibronectin type III domain containing 
5 (FNDC5), which is a transmembrane protein. 
Irisin is believed to be promising in the treatment 
and monitoring of obesity, diabetes, cardiovascular 
and central nervous system diseases (MAHGOUB 
et al., 2018).
Up to our best knowledge and literature survey, 
there are no previous reports on the relationship 
between kumiss and weight loss and irisin and 
nesfatin-1 hormones. Only one recent study 
reported that an increase in hypothalamic nesfatin-1 
inhibits feeding behavior and increases weight loss. 
In that study, it was stated that feeding behaviors 
were regulated through MC3/4R-ERK signalling 
but its mechanism was still unclear (ZHANG et 
al., 2019). In a study we conducted in 2019, we 
recently investigated the effects of kumiss on some 
biomolecules associated with cancer signaling 
pathways and antioxidant systems under chronic 
stress (GULMEZ and ATAKISI, 2019). In contrast 
to the study purpose, a decrease in the weight of the 
mice was observed. This result inspired the present 
study. The aim of this study was to investigate the 
plasma and tissue levels of nesfatin-1 and irisin 
hormones, which were discovered in recent years 
and are associated with endocrine and metabolic 
functions, in kumiss-supplemented mice. This 
study is also important for determining whether 
there is a relationship between weight loss, food 
intake and the tissue distributions and levels of 
these hormones.
material and methods
Subjects. In the study, sixteen male Balb-c 
mice were used, weighing 20-25 g. Prior to the 
trial, permission was obtained from the Local 
Ethics Committee of the Animal Experiments of 
the Kafkas University (KAU-HADYEK / 2018-
072). The housing, maintenance and experimental 
procedures were carried out at the Experimental 
Animal Unit of Kafkas University. The animals 
were maintained in special cages without any 
contact between the groups, and all groups were fed 
with ad libitum-balanced diet. They were kept in 
a12 hours light and 12 hours dark cycle at constant 
room temperature (19-21 °C).
Experimental design. The subjects were divided 
into two groups: (1) control group (n = 8) and (2) 
experimental group (n = 8). The control group 
did not receive any special treatment during the 
experiment and normal feeding conditions were 
achieved. The kumiss group was given kumiss once 
a day orally for 20 weeks. The weights and food 
intake of the animals were monitored during the 
experiment. At the end of the experiment, the mice 
were sacrificed under anesthesia (combination of 
xylazine (15 mg/kg) and ketamine (50 mg/kg)) and 
the intracardiac blood samples from animals were 
centrifuged at 3000 rpm and +4 °C for 15 minutes 
to separate the plasma. The liver, kidney and brain 
tissues were homogenized using cold lysis buffer 
containing 10 µg/mL aprotinin (from 10 mg/mL 
stock in water; stored at -20 oC).
Preparation and application of the kumiss. The 
kumiss was purchased from the Alaş Kumiss Farm 
(Izmir, Turkey). Kumiss was used as fresh and kept 
at 4 °C in the refrigerator. The determination of 
the total number of specific live microorganisms 
in kumiss samples was determined according to 
the method proposed by KANDLER and WEISS 
(1986). The typical bacterial colony number of each 
medium was calculated as 2×108 cfu/mL and the 
mice were allowed to take 2×108 cfu/mL bacteria 
colony daily. During the experiment, the kumiss 
was added to the drinking water of mice at a ratio of 
1:1, to obtain a daily 2×108 cfu/mL bacterial colony. 
The physical and chemical properties of the kumiss 
and feed are collectively presented in Table 1 and 2.
Table 1. Analysis of Kumiss
Analysis Result of analysis
Ethyl alcohol 1.2% ± 0.07
Ash 0.43%
Total amount of oil 4% ± 0.045
Dry matter content 7.32% ± 0.17
Humidity 92.68% ± 2.13
Density 1.016 g/cm3 ± 0.004
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Energy (kcal /kg) 2650
Biochemical analysis. Plasma and all tissues 
were stored at -45 °C. The nesfatin-1 and 
irisin levels in plasma and tissue samples were 
determined using commercial mouse ELISA kits. 
The protein concentrations of the tissue samples 
were analyzed by the Bradford method, using 
bovine serum albumin (BSA) as the standard, at 
595 nm (BRADFORD, 1976).
Statistical analysis. Statistical analyses were 
performed in triplicate, and average values with 
standard deviation (mean ± SD) are reported. 
The statistical significance was evaluated using 
the SPSS 16.0 software package (SPSS ver. 16.0 
for windows professional edition). A one-way 
analysis of variance (ANOVA) was performed 
and was followed by Duncan’s test to estimate the 
significance at the 5% probability level.
Results
The live weights (g) of the animals were 
recorded for 20 weeks (Fig. 1). When live weights 
were examined, there were statistically significant 
differences between the control and kumiss groups 
for 2-12 weeks (P<0.05). Kumiss supplementation 
reduced the live weight during this process. 
However, no significant difference was observed 
after the 12th week.
The mice were fed daily with an ad libitum 
balanced diet, and feed consumption was monitored 
for 20 weeks (Fig. 2). The feed consumption of 
both control and kumiss groups increased over 
time. The feed consumption in the kumiss group 
was significantly lower at the beginning (0-10th 
week), the 10th week and at the end (10-20th week) 
compared to the control group (P<0.05).
The nesfatin-1 and irisin levels in the liver, 
kidney, brain and plasma samples were investigated 
(Fig. 3 and 4). The results obtained showed that 
there was no significant difference in the levels of 
irisin and nesfatin-1 in the kidney and brain tissues 
between the groups. However, the plasma levels 
of nesfatin-1 and irisin decreased (P<0.001) while 
the liver levels increased (P<0.05 and P<0.001, 
respectively).
Fig. 1. Live weights (g) of mice. The live weights (g) of the animals were recorded for 20 weeks.
C. Gulmez and O. Atakisi: The effects of kumiss supplementation on body weight, food intake, nesfatin-1 and irisin levels  
in BALB/C mice
Vet. arhiv 90 (6), 627-636, 2020630
Fig. 3. Biochemical investigation results. Nesfatin-1 levels of plasma (A), liver tissue (B), kidney tissue (C) and 
brain tissue (D). *Compared to the control group, P<0.001 (A) and P<0.05 (B). The results for kidney and brain 
tissues are not statistically significant.
Fig. 2. Feed consumption (g) of mice. The feed consumption of mice was monitored for 20 weeks. 
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Discussion
The aim of this study was to investigate the 
effects of kumiss on weight loss, food intake, 
plasma and tissue nesfatin-1 and irisin levels. 
Probiotics have physiological functions that 
regulate the intestinal microbiota, and contribute to 
the health of the host environment. Backslopping 
fermentation technology has been the main 
method for manufacturing kumiss. However, 
the products obtained by this method have some 
deficiencies in consistency, especially with regard 
to microbiological diversity and physicochemical 
and nutritional characteristics (LI et al., 2019). The 
kumiss microbiota was very rich in Lactococcus and 
Streptococcus, particularly Lactobacillus helveticus 
and Lactobacillus kefiranofaciens (YAO et al., 
2017). It is thought that beneficial effects of kumiss 
are related to the kumiss metabolites as well as the 
rich bacteria content. The production mechanisms 
of these metabolites are unclear, but some result 
directly from the activity of the kumiss microbiota. 
Lactobacillus species produces hexanoic acid 
(WALSH et al., 2016), pyroglutamicacid (KANJAN 
and HONGPATTARAKERE, 2016), L-glutamaic 
acid (ZAREIAN et al., 2012) and pyridoxine 
(OGURO et al., 2017). Some important dipeptides 
are also formed in the fermentation process, such 
as methionylasparagine, prolylasparagine and 
lysylvaline, but also biotin, 2′-deoxy5′-adenylic 
acid, S-adenosyl-L-methionine, carnosine and 
lysophosphatidylinositol (HOU et al., 2019).
In experimental studies, Lactobacillus and 
Bifidobacterium bacteria have been reported to 
have beneficial effects on metabolic syndrome, 
such as weight loss, fat reduction in the internal 
organs and glucose tolerance (LE CHATELIER and 
NIELSEN 2013). In most cases, weight loss occurs 
in coordination with thermogenic and lipolytic 
responses by stimulating the sympathetic nervous 
system (KARIMI et al., 2015). Probiotic strains, 
Lactobacillus gasseri BNR17, have demonstrated 
the ability to prevent increase in adipocyte tissue, 
the main source of leptin and adiponectin, and thus 
limit leptin secretion (KANG et al., 2013). AN et al. 
(2011) found that body and fat weights were reduced 
in mice fed a diet supplemented with lactic acid 
bacteria supplement (B. pseudocatenulatum SPM 
1204, B. longum SPM 1205, and B. longum SPM 
Fig. 4. Biochemical investigation results. Irisin levels of plasma (A), liver tissue (B), kidney tissue (C) and brain tissue (D). 
* Compared to the control group, P<0.001. The results for kidney and brain tissues are not statistically significant.
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1207, 108~109 CFU/0.2 mL, daily) for 5 weeks. 
Lactobacillus gasseri BNR17 (final, concentration 
of 109 CFU/0.5 mL, twice a day) administered to 
female Sprague-Dawley rats for 8 weeks was found 
to reduce both weight gain (g/day) and final weight 
(g) compared to the control (KANG et al., 2010). 
In another study, male C57BL/6 mice were given 
low (1×107 CFU) and high dose (1×109 CFU) 
Lactobacillus plantarum LG4 with a high fat (HF) 
diet for 12 weeks. Both HG+low (16.62 ± 3.71) 
and HG+high (14.08 ± 6.1) doses of Lactobacillus 
plantarum LG4 groups were reported to reduce 
weight gain compared to the HG group (22.62 ± 
1.24). In addition, when compared with the HG and 
control groups, it was determined that food intake 
decreased in Lactobacillus plantarum LG4 treated 
groups (PARK et al., 2014). But in another study, 
there was no difference in the weights of male 
C57BL/6 mice treated with L. acidophilus NCDC 
13 (5×107~9×107 CFU/mL, daily, for 8 weeks) 
and male-female Sprague Dawley albino rats 
treated with Lactobacillus plantarum LS/07 and 
Lactobacillus plantarum Biocenol LP9 (3×109 CFU, 
daily, for 10 weeks) compared to the control and 
high fat diet groups (ARORA et al., 2012; SALAJ 
et al., 2013). In the present study, when the live 
weight of the animals in the groups was examined, 
it was observed that the live weights of the kumiss 
group decreased significantly over 2-12 weeks 
(P<0.05). When the control and kumiss groups were 
compared, no significant difference was observed 
in the live weights after 12 weeks. The effect of 
kumiss on the decrease in live weight may be an 
important result of the multifaceted effect of the 
bacteria or other components available it contains, 
and its regulation of the whole metabolism.
Nesfatin-1, a hormone described by OH-I et 
al. (2006), suppresses food intake. This hormone 
is formed by proteolysis of the nucleobindin 2 
protein (NUCB2). Nesfatin-1, also referred to as 
anorexigenic hormone, is associated with diabetes, 
obesity, anorexia nervosa, psychiatric disorders and 
neurogenic diseases, and its levels are mostly found 
in the central nervous system, as well as in the 
pancreas, testis, adipose tissue, pituitary gland, and 
stomach (OH-I et al., 2006; DAI et al., 2013). In one 
study, it was reported that fasting increases ghrelin 
hormone, and decreases nesfatin-1, and nesfatin-1 
has anorexigenic and anti-hyperlipidemic effects 
(UNAL et al., 2018). High levels of nesfatin-1 are 
found in the hypothalamic nucleus and brainstem 
areas that are known to be associated with food intake 
and metabolism regulation. The protein expressions 
and mRNA of nesfatin-1 in the hypothalamic 
paraventricular nucleus and supraoptic nucleus was 
affected by energy changes after acute or chronic 
malnutrition (OH-I et al., 2006; BECKERS et al., 
2009). Intraperitoneal nesfatin-1 injection has been 
reported to affect the expression of appetite factors 
to inhibit the food intake of Siberian sturgeon 
(ZHANG et al., 2018a). In another study by the 
same author, it was determined that fasting affects 
NUCB2 levels in the liver and brain. Acute and 
chronic nesfatin-1 injections have been reported 
to inhibit food intake and affect the expression of 
appetite factors in Siberian sturgeon (ZHANG et 
al., 2018b). It has been founded that an increase in 
food uptake suppressors (such as cholecystokinin, 
MSH) increases mRNA expression of NUCB2, and 
activates nesfatin-1-immunopositive neurons in 
the hypothalamus and brainstem (GOEBEL et al., 
2009). The synthesis and release of nesfatin-1 are 
altered by relative amounts of nutrients, and this 
effect varies according to the amount of nutrients, 
the duration of treatment, the frequency, and the 
tissue. In the study by MOHAN et al. (2018), a fat 
diet inhibited nesfatin-1 while it was stimulated by 
a protein and carbohydrate diet. The conclusion 
that the nesfatin-1 level is modulated by diet is 
consistent with the findings of this study. In the 
study conducted by KUYUMCU et al. (2019) 
reported that there was a positive relationship 
between median diet and nesfatin-1 concentration, 
and diet and nesfatin 1 levels were independent 
protective variables for chronic arterial disease. 
In this study, kumiss influenced plasma and 
tissue levels of nesfatin-1, as well as food intake, 
and body weight decreased. It has been determined 
that plasma levels of nesfatin-1 decreased while the 
liver levels increased (P<0.001) and the kidney and 
brain levels did not change. Nesfatin-1 has been 
shown to be effective in regulating feeding habits, 
food intake, body weight and glucose balance in 
rats (RODGERS et al., 2012). Nesfatin-1 is thought 
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to exert an appetite-regulating effect, independent 
of many neurotransmitter systems, with other 
anorexinogenic molecules, and especially through 
leptin or melanocortin (BECKERS et al., 2009). In 
a study of obese and morbidly obese individuals, 
a significant relationship was found between body 
fat percentage and circulating nesfatin-1 levels. 
High calorie, carbohydrate and protein intake in 
obese individuals has been associated with lower 
nesfatin-1 levels (MIRZAEI et al., 2015). FINELLI 
et al. (2014) reported that the data obtained in basic 
experiments on nesfatin-1 may be useful for the 
development of a new anti-obesity treatment. 
Nesfatin-1, phoenixin, spexin and kisspeptin 
have been reported to be novel multifunctional 
neuropeptides of the brain, and these neuropeptides 
play a role in regulating nutrient uptake and anxiety 
responses (PAŁASZ et al., 2018). However, in this 
study, kumiss supplementation did not lead to a 
change in brain and kidney nesfatin-1 levels. When 
the literature was examined, a limited number of 
studies were found on the connection between food 
intake and body weight and nesfatin-1 level. We 
found that weight loss and a reduction in food intake 
was associated with plasma and tissue nesfatin-1 
levels. With the effect of kumiss, nesfatin-1 may 
influence appetite factors to reduce food intake 
through various signaling pathways. 
Irisin is considered as potential biomarker in 
metabolic syndrome and obesity, due to its ability 
to turn white adipose tissue to brown adipose tissue. 
The increase in the amount of brown fat tissue 
in the body provides weight control and energy 
balance protection (CHOI et al. 2013). In different 
studies, irisin has been reported to have a protective 
effect on hepatic metabolism by improving glucose 
uptake glucose tolerance, and hepatic glucose and 
lipid metabolism (SO and LEUNG, 2016; XIN 
et al., 2016). CASTILLO-QUAN (2012) was 
reported to lead to improvements in obesity and 
glucose homeostasis. Moreover, it was found that 
irisin increases secretion of glycerol, decreases 
lipid accumulation, and inhibits hepatic cholesterol 
synthesis (GAO et al., 2018; TANG et al., 2016). 
Irisin in mice has been shown to cause obesity-
related insulin resistance, and a significant increase 
in total body energy consumption (TIMMONS et 
al., 2012). In this study, as in the case of nesfatin-1, 
the liver levels of the irisin increased with kumiss 
supplementation, while kidney and brain levels 
did not change. UYSAL et al. (2018) suggest that 
the decrease in anxiolytic behavior due to regular 
voluntary exercise may be associated with locally 
produced brain irisin. It has been shown that 
recombinant irisin attenuated kidney damage and 
improved renal function in mice. Plasma levels of 
irisin have been reported to be regulated by diet, 
obesity, lipid profile, exercise, pharmacological 
agents and different pathological conditions 
(MAHGOUB et al., 2018). In a study, healthy eating 
habits were associated with low irisin levels, whereas 
a high carbohydrate diet was associated with high 
irisin levels. The circulating irisin concentrations 
are positively correlated with body mass index, 
fasting blood glucose and total cholesterol. It has 
also been reported that after weight loss due to 
obesity surgery, circulating irisin levels, as well as 
muscle FNDC5 gene expression, are significantly 
reduced (MORENO-NAVARRETE et al., 2013). In 
another study, the circulating irisin level was higher 
in obese individuals, and was positively associated 
with total bone mass density, muscle, and fat masses 
after surgery (LU et al., 2019).
Irisin is stimulated by exercise in mice and 
humans, and a slight increase in the circulating level 
of irisin leads to an increase in energy expenditure, 
with no change in movement or food intake 
(CASTILLO-QUAN, 2012). However, in this study, 
kumiss reduced both irisin plasma levels and food 
intake. The weight loss in mice may be a result of the 
influence on various metabolic processes by kumiss, 
particularly food intake and appetite, through the 
irisin and nesfatin-1 hormones. The suppression 
of irisin was reported to reduce food intake and a 
decrease in irisin modulated metabolic peptides in 
zebra fish. BUTT et al. (2017) suggest that irisin is 
an anorexigenic factor, and its effects are partially 
mediated by appetite-regulating factors. Irisin 
infusion has been shown to increase food intake and 
does not alter body weight in rats. It was also found 
to decrease serum leptin level and increase ghrelin 
level. In the first study, it has been suggested that 
irisin exercises its physiological properties through 
a cell surface receptor (BOSTROM et al., 2012). 
C. Gulmez and O. Atakisi: The effects of kumiss supplementation on body weight, food intake, nesfatin-1 and irisin levels  
in BALB/C mice
Vet. arhiv 90 (6), 627-636, 2020634
Despite increasing knowledge about the circulating 
effects of irisin, the receptor (or receptors) that 
mediate these effects remains to be discovered. 
Conclusion
In the present study, it was observed that the 
kumiss administered to mice for 5 months reduced 
body weight and food intake, and affected plasma 
and liver levels of nesfatin-1 and irisin hormones. 
To date, no study showing the relationship between 
kumiss use and nesfatin and irisin hormones has 
been found. The mechanism underlying reductions 
in body weight is not yet known, the influence of 
kumiss on weight loss and food intake is a result 
of the multifunctional effects of its components or 
bacteria, and regulation of the whole metabolism. 
Somehow, with the effect of kumiss, nesfatin-1 
and irisin hormones may influence appetite factors 
to reduce food intake through various signaling 
pathways. The results indicate that irisin and 
nesfatin-1 levels are regulated by diet and are 
effective in weight loss and food intake.
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sAžeTAk
Cilj ovoga rada bio je istražiti razine nesfatina-1 i hormona irizina, koji su nedavno otkriveni i povezani su s 
endokrinim i metaboličkim funkcijama, u plazmi i tkivu miševa hranjenih dodatkom kumisa. Šesnaest BALB/C 
muških jedinki podijeljeno je u dvije skupine, kontrolnu i pokusnu. Za vrijeme istraživanja kumis je dodavan u vodu 
za piće u omjeru 1 : 1, kako bi se dnevno postiglo  2×108 cfu/mL bakterijskih kolonija, te je davan jedanput dnevno 
peroralno tijekom 20 tjedana. Praćeni su porast tjelesne mase i unos hrane. Razine nesfatina-1 i irizina u uzorcima 
plazme i tkiva određene su ELISA-om. Dodatak kumisa utjecao je na smanjenje tjelesne mase između 2. i 12. tjedna 
(P < 0,05). Nije uočena znakovita razlika nakon 12. tjedna. Unos hrane u pokusnoj skupini smanjen je na početku i 
deseti tjedan te je na kraju uspoređen s kontrolnom skupinom (P < 0,05). Razine nesfatina-1 i irizina u plazmi (P < 
0,001) su se smanjile, dok su razine u jetri porasle (nesfatin-1 P < 0,05;  irizin P < 0,001). Rezultati upućuju na to da 
su razine  nesfatina-1 i irizina u plazmi i jetri regulirane prehranom i djeluju na smanjenje tjelesne mase i unos hrane. 
ključne riječi: kumis; gubitak tjelesne mase; unos hrane; irizin; nesfatin-1_____________________________________________________________________________________________
